Engineering a Cell-Free Murein Biosynthetic Pathway: Combinatorial Enzymology in Drug Discovery-Reference-Cited by-同舟云学术

Engineering a Cell-Free Murein Biosynthetic Pathway: Combinatorial Enzymology in Drug Discovery

Published:1998-12-01 Issue:51 Volume:120 Page:13527-13528
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Wong Kenny K.¹,Kuo David W.¹,Chabin Renee M.¹,Fournier Carole¹,Gegnas Laura D.¹,Waddell Sherman T.¹,Marsilio Frank¹,Leiting Barbara¹,Pompliano David L.¹

Affiliation:

1. Departments of Biochemistry and Medicinal Chemistry Merck Research Laboratories, P.O. Box 2000 Rahway, New Jersey 07065-0900

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja983468z

Reference14 articles.

1. High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion System

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases;Journal of Enzyme Inhibition and Medicinal Chemistry;2019-01-01

2. An update on the use ofC. elegansfor preclinical drug discovery: screening and identifying anti-infective drugs;Expert Opinion on Drug Discovery;2017-04-21

3. Lead Discovery and Lead Modification;The Organic Chemistry of Drug Design and Drug Action;2014

4. Viable screening targets related to the bacterial cell wall;Annals of the New York Academy of Sciences;2012-12-26

5. Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus;ACS Medicinal Chemistry Letters;2012-07-02